These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 8382247)

  • 61. Effect of interferon-alpha on neutrophil functions.
    Kasimir S; Brom J; König W
    Immunology; 1991 Oct; 74(2):271-8. PubMed ID: 1660854
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Mutations of F110 and C126 of the formyl peptide receptor interfere with G-protein coupling and chemotaxis.
    Jones BE; Miettinen HM; Jesaitis AJ; Mills JS
    J Periodontol; 2003 Apr; 74(4):475-84. PubMed ID: 12747452
    [TBL] [Abstract][Full Text] [Related]  

  • 63. G protein activation by human dopamine D3 receptors in high-expressing Chinese hamster ovary cells: A guanosine-5'-O-(3-[35S]thio)- triphosphate binding and antibody study.
    Newman-Tancredi A; Cussac D; Audinot V; Pasteau V; Gavaudan S; Millan MJ
    Mol Pharmacol; 1999 Mar; 55(3):564-74. PubMed ID: 10051542
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The ligand binding site of the formyl peptide receptor maps in the transmembrane region.
    Miettinen HM; Mills JS; Gripentrog JM; Dratz EA; Granger BL; Jesaitis AJ
    J Immunol; 1997 Oct; 159(8):4045-54. PubMed ID: 9378994
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Philadelphia chromosome-positive chronic myelogenous leukemia: functional defects in circulating mature neutrophils of untreated and interferon-alpha-treated patients.
    Kasimir-Bauer S; Ottinger H; Brittinger G; König W
    Exp Hematol; 1994 May; 22(5):426-31. PubMed ID: 8174673
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Functional molecular complexes of human N-formyl chemoattractant receptors and actin.
    Jesaitis AJ; Erickson RW; Klotz KN; Bommakanti RK; Siemsen DW
    J Immunol; 1993 Nov; 151(10):5653-65. PubMed ID: 8228254
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of in vitro differentiation on phorbol diester receptor number in human promyelocytic leukemia (HL-60) cells.
    Lane RW; Sturm RJ; Borzelleca JF; Carchman RA
    Cancer Res; 1986 Aug; 46(8):3782-8. PubMed ID: 3460690
    [TBL] [Abstract][Full Text] [Related]  

  • 68. An immunosuppressive retrovirus-derived hexapeptide interferes with intracellular signaling in monocytes and granulocytes through N-formylpeptide receptors.
    Oostendorp RA; Knol EF; Verhoeven AJ; Scheper RJ
    J Immunol; 1992 Aug; 149(3):1010-5. PubMed ID: 1634759
    [TBL] [Abstract][Full Text] [Related]  

  • 69. S-prenylated cysteine analogues inhibit receptor-mediated G protein activation in native human granulocyte and reconstituted bovine retinal rod outer segment membranes.
    Scheer A; Gierschik P
    Biochemistry; 1995 Apr; 34(15):4952-61. PubMed ID: 7711017
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Leukocyte stimulation: receptor, membrane, and metabolic events. Introduction and summary.
    Becker EL
    Fed Proc; 1986 Jun; 45(7):2148-50. PubMed ID: 3011522
    [No Abstract]   [Full Text] [Related]  

  • 71. G-protein-coupled receptors in HL-60 human leukemia cells.
    Klinker JF; Wenzel-Seifert K; Seifert R
    Gen Pharmacol; 1996 Jan; 27(1):33-54. PubMed ID: 8742493
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Na+ regulation of formyl peptide receptor-mediated signal transduction in HL 60 cells. Evidence that the cation prevents activation of the G-protein by unoccupied receptors.
    Gierschik P; Sidiropoulos D; Steisslinger M; Jakobs KH
    Eur J Pharmacol; 1989 Dec; 172(6):481-92. PubMed ID: 2515070
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cross-desensitization of chemoattractant receptors occurs at multiple levels. Evidence for a role for inhibition of phospholipase C activity.
    Richardson RM; Ali H; Tomhave ED; Haribabu B; Snyderman R
    J Biol Chem; 1995 Nov; 270(46):27829-33. PubMed ID: 7499254
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Granulocytic differentiation induced by retinoic acid in HL-60 cells is associated with changes in adenylate cyclase activity.
    Thomas G; Chomienne C; Balitrand N; Schaison G; Abita JP; Baulieu EE
    Anticancer Res; 1986; 6(4):857-60. PubMed ID: 3092726
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Chemotactic factor binding and functional capacity: a comparison between human granulocytes and differentiated HL-60 cells.
    Dahlgren C; Andersson T; Stendahl O
    J Leukoc Biol; 1987 Sep; 42(3):245-52. PubMed ID: 3040876
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The degranulation response in differentiated HL-60 cells.
    Meagher LC; Cotter TG
    Clin Exp Immunol; 1988 Dec; 74(3):483-8. PubMed ID: 2853019
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Functional maturation of membrane potential changes and superoxide-producing capacity during differentiation of human granulocytes.
    Kitagawa S; Ohta M; Nojiri H; Kakinuma K; Saito M; Takaku F; Miura Y
    J Clin Invest; 1984 Apr; 73(4):1062-71. PubMed ID: 6200501
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Identification of putative sites of interaction between the human formyl peptide receptor and G protein.
    Miettinen HM; Gripentrog JM; Mason MM; Jesaitis AJ
    J Biol Chem; 1999 Sep; 274(39):27934-42. PubMed ID: 10488141
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Functionally nonequivalent interactions of guanosine 5'-triphosphate, inosine 5'-triphosphate, and xanthosine 5'-triphosphate with the retinal G-protein, transducin, and with Gi-proteins in HL-60 leukemia cell membranes.
    Klinker JF; Seifert R
    Biochem Pharmacol; 1997 Sep; 54(5):551-62. PubMed ID: 9337071
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Differential expression of cytosolic activation factors for NADPH oxidase in HL-60 leukemic cells.
    Seifert R; Jungblut P; Schultz G
    Biochem Biophys Res Commun; 1989 Jun; 161(3):1109-17. PubMed ID: 2472788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.